Form 8-K - Current report:
SEC Accession No. 0000950170-24-091813
Filing Date
2024-08-06
Accepted
2024-08-06 16:11:38
Documents
13
Period of Report
2024-08-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rptx-20240806.htm   iXBRL 8-K 40761
2 EX-99.1 rptx-ex99_1.htm EX-99.1 209403
3 GRAPHIC img233743075_0.jpg GRAPHIC 3037
  Complete submission text file 0000950170-24-091813.txt   385076

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT rptx-20240806.xsd EX-101.SCH 25786
15 EXTRACTED XBRL INSTANCE DOCUMENT rptx-20240806_htm.xml XML 4883
Mailing Address 7171 FREDERICK BANTING SUITE 270, BUILDING 2 SAINT-LAURENT A8 H4S 1Z9
Business Address 7171 FREDERICK BANTING SUITE 270, BUILDING 2 SAINT-LAURENT A8 H4S 1Z9 (857) 412-7018
Repare Therapeutics Inc. (Filer) CIK: 0001808158 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39335 | Film No.: 241179341
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)